Consistent with these observations, the expression levels of REL/NFκB transcription factors classified our ESR1-negative BRCA1 tumours in the same way as observed for the complete gene-set #2, with two main subclasses (a and b) that differed in the magnitude of expression change of immune response genes (but not in the direction) (Figure 3B). This evidence concerns the gene REL and neoplasm.